drugstr
Central, NJ
Male, 61
I have worked as a drug discovery scientist for over 30 years performing experiments to help identify novel chemical compounds for their potential in treating diseases in the areas of infection, inflammation and cardiovascular disorders. I have a good familiarity with the entire process from discovery to safety to clinical trials and even marketing. Ask me about the business of Big Pharma. I’m happy to comment on any and all hot-button issues. My opinions are quite often not pro-business.
I have the same questions. The answers are not very clear. The FDA has approved its use for certain rare seizure disorders and is useful in reducing nausea and vomiting in cancer chemotherapy patients. Other common claims, not formerly established indications, are chronic pain, inflammation, anxiety, appetite and several mental health conditions. Best usage - replace opiates for chronic pain. Judging effectiveness clinically has got to be difficult since therapeutic success is subjective. I imagine it's hard to identify a patient's true need versus desire for it. As far as safety goes, there are the dangers associated with intoxication and smoking probably carries risks similar to tobacco.
Thank you for bringing this to my attention. I hadn't seen this. I'm very familiar with this drug, ivermectin, IVM. It was discovered and developed in the U.S. in the 70's. Its primary use is in animal medicine for the treatment of worms in the GI tract. The Australian discovery is very exciting. They showed that IVM blocks COVID-19 in vitro (petri dish) and clinical trials are underway to test its effectiveness in humans with the disease. From what little I've read, the levels of IVM used in vitro will be difficult to achieve in the blood of patients when dosed orally, the only route of administration currently approved. Nevertheless, it may work at low levels. A successful IV safety study might be worth trying. Time will tell.
No I haven't. I never worked with patients nor am I aware of any one dying from an adverse event while on a drug that I was involved in developing.
Sorry for the late response. I hope you're doing well and enjoying the program. I think that your training would prepare you well for your goal. I have seen Pharm. D.s working at all levels, but I must say that research leadership tends to be composed mainly of PhDs and MDs. Still, your success will depend entirely on your skills and ambition. Good luck!
School Teacher
How do you feel about the idea of year-round schooling?Meter Maid
Is it tough to have a job that consists exclusively of ruining peoples' days?Fashion Model
What's the most lucrative type of gig models can book?Millions of people around the world rely on plant-based remedies for treating their ailments and I would never say that they are making a mistake. There's often thousands of years of experience behind this practice. It's well known that a vast number of pharmacological agents originated from biology. I myself prefer only to use the specific compounds derived from these materials for two reasons. First, it avoids the complications that might exist from other components in the material. For example, I wouldn't eat a fungus for the penicillin. And second, I'm confident that the pure drug has been demonstrated to be safe, is appropriate for my condition and is dosed properly for effectiveness. I believe that herbal medicines currently marketed in the US are generally safe, but like other non-FDA approved supplements for weight-loss, BPH, memory, etc. their health claims are dubious. Nevertheless, if it works for you, go ahead and use it.
Administering convalescent plasma, or for that matter monoclonal anti-covid antibody, is referred to as passive immunity. It will no doubt be useful for patients in whom virus is circulating in the blood stream. This may well be life-saving in these patients, but it would not be expected to prevent infection which is initiated outside of the blood stream. There's more to immunity than antibodies. There's a cellular component which serves to combat invading pathogens by surveillance and direct destruction. It's not clear how important this is for disease protection or whether vaccines will generate this cellular immunity. It's possible that true immunity may only be gained by actual infection and, unfortunately, may not be permanent.
This is not a pharma question.No numbers have been changed. Evidently, a CDC report on comorbidities was the source of this misinformation.
-OR-
Login with Facebook(max 20 characters - letters, numbers, and underscores only. Note that your username is private, and you have the option to choose an alias when asking questions or hosting a Q&A.)
(A valid e-mail address is required. Your e-mail will not be shared with anyone.)
(min 5 characters)
By checking this box, you acknowledge that you have read and agree to Jobstr.com’s Terms and Privacy Policy.
-OR-
Register with Facebook(Don't worry: you'll be able to choose an alias when asking questions or hosting a Q&A.)